Literature DB >> 16630892

Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo.

P Pavan Kumar1, Prabhat Kumar Purbey, Chandan Kumar Sinha, Dimple Notani, Amita Limaye, Ranveer S Jayani, Sanjeev Galande.   

Abstract

SATB1 regulates gene expression by acting as a "docking site" for several chromatin remodeling enzymes and also by recruiting corepressors (HDACs) or coactivators (HATs) directly to promoters. However, how these contrasting effectors act at the level of SATB1 is not clear. We show here that phosphorylation by PKC acts as a switch to determine whether SATB1 interacts with HDAC1 or PCAF. Phosphorylation and dephosphorylation of SATB1 exerted opposing effects on MAR-linked reporter activity in vivo. SATB1 interacted with both CBP/p300 and PCAF HATs; however, these interactions resulted in the acetylation of the PDZ-like domain of SATB1 by PCAF but not by CBP/p300 and resulted in loss of its DNA binding activity. Using the T cell activation model, we provide mechanistic insights into how IL-2 transcription is reciprocally governed by the phosphorylation status of SATB1 and propose that a similar mechanism may dictate the ability of SATB1 to function as a global regulator.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630892     DOI: 10.1016/j.molcel.2006.03.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  84 in total

Review 1.  Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Authors:  Luca Gattinoni; Yun Ji; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2010-08-05       Impact factor: 12.531

Review 2.  Genome organizing function of SATB1 in tumor progression.

Authors:  Terumi Kohwi-Shigematsu; Krzysztof Poterlowicz; Ellen Ordinario; Hye-Jung Han; Vladimir A Botchkarev; Yoshinori Kohwi
Journal:  Semin Cancer Biol       Date:  2012-07-04       Impact factor: 15.707

3.  Decondensing the protamine domain for transcription.

Authors:  Rui Pires Martins; Stephen A Krawetz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

4.  SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage.

Authors:  Joseph-Anthony T Tan; Yujie Sun; Jing Song; Yuan Chen; Theodore G Krontiris; Linda K Durrin
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

5.  Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.

Authors:  Joseph-Anthony T Tan; Jing Song; Yuan Chen; Linda K Durrin
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

6.  Effect of baicalein on the expression of SATB1 in human breast cancer cells.

Authors:  Xiao-Yan Gao; Xing-Huan Xue; Yi-Nan Ma; Shu-Qun Zhang
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

Review 7.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

8.  Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.

Authors:  Xue-Feng Fang; Zhi-Bo Hou; Xin-Zheng Dai; Cong Chen; Jing Ge; Hong Shen; Xiao-Feng Li; Li-Ke Yu; Ying Yuan
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

9.  Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.

Authors:  Dimple Notani; Kamalvishnu P Gottimukkala; Ranveer S Jayani; Amita S Limaye; Madhujit V Damle; Sameet Mehta; Prabhat Kumar Purbey; Jomon Joseph; Sanjeev Galande
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

10.  The mRNA expression of SATB1 and SATB2 in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Mansel; Robert Newbold; Kefah Mokbel
Journal:  Cancer Cell Int       Date:  2009-07-30       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.